Patient (sex) | Age (years) | TTP (months) | RT dose (dose per fraction) | RT modality | Recurrence |
---|---|---|---|---|---|
Analysis of recurrence patterns in the primary group | |||||
1 (f) | 24 | 41 | 60.0 (2.0) | proton | out-field |
2 (f) | 65 | 72 | 59.4 (1.8) | 3D-conformal | out-field |
3 (f) | 47 | 225 | 57.6 (1.8) | 3D-conformal | out-field |
4 (f) | 44 | 86 | 57.6 (1.8) | 3D-conformal | out-field |
5 (f) | 63 | 62 | 55.8 (1.8) | 3D-conformal | in-field |
6 (f) | 36 | 85 | 60.0 (2.0) | 3D-conformal | in-field |
7 (f) | 52 | 91 | 54.0 (1.8) | 3D-conformal | in-field |
8 (m) | 52 | 72 | 60.0 (2.0) | IMRT | in-field |
9 (f) | 54 | 38 | 60.0 (2.0) | IMRT | out-field |
10 (f) | 64 | 17 | 59.4 (1.8) | 3D-conformal | in-field |
11 (f) | 43 | 89 | 54.0 (1.8) | 3D-conformal | out-field |
12 (f) | 68 | 71 | 54.0 (1.8) | 3D-conformal | in-field |
13 (m) | 39 | 217 | 59.4 (1.8) | 3D-conformal | out-field |
14 (m) | 29 | 74 | 54.0 (1.8) | IMRT | out-field |
Patient (sex) | Age (years) | TTP (months) | RT dose (dose per fraction) | RT modality | Recurrence |
---|---|---|---|---|---|
Analysis of recurrence patterns in the recurrence group | |||||
4 (f) | 52 | 16 | 45.0 (3.0) | C12-ions | out-field |
6 (f) | 43 | 15 | 51.0 (3.0) | C12-ions | in-field |
7 (f) | 60 | 24 | 40.0 (2.0) | 3D-conformal | in-field |
8 (m) | 59 | 36 | 51.0 (2.0) | C12-ions | in-field |
9 (f) | 59 | 9 | 51.0 (3.0) | C12-ions | out-field |
10 (f) | 65 | 1 | 51.0 (3.0) | C12-ions | out-field |
13 (m) | 57 | 29 | 18.0 (18.0) | Cyberknife | in-field |